Reactosome is building a new generation of intracellular medicine. Our Synthetic Nucleus is a non-viral, redosable delivery platform that carries payloads three times larger than AAV — unlocking gene therapies, sustained peptide release, and regenerative treatments for diseases that today's tools can't touch. Starting with restoring vision in inherited retinal disease.
| Website | https://reactosome.com/ |
| Employees | 6 (3 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
| Keywords | Gene Therapy, Synthetic Biology, Genetic Engineering, Genetic Modification, Genome Editing, Cellular Reprogramming, Cell Therapy, Gene Transfer, Cargo Delivery, Advanced Therapy Medicinal Products, Biotechnology, Molecular Engineering, Drug Delivery |
Looking for a particular Reactosome employee's phone or email?
Reactosome Questions
Ksenia Burka is the Co-founder, Chief Executive Officer of Reactosome.
3 people are employed at Reactosome.
Reactosome is based in San Francisco, California.
Top Reactosome Employees
-
Ksenia Burka
Co-founder, Chief Executive Officer at Reactosome
San Francisco, CA, US1 -
Ekaterina Konshina
Research Coordinator at Reactosome
Boston, MA, US
G2Crowd Trusted
300K+
Plugin Users
